Ebsteins anomaly of the tricuspid valve other diagnostic studies

Revision as of 14:57, 10 October 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Ebsteins anomaly of the tricuspid valve Microchapters

Home

Patient Information

Overview

Historical Perpective

Classification

Pathophysiology

Causes

Differentiating Ebstein's Anomaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Ebsteins anomaly of the tricuspid valve other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebsteins anomaly of the tricuspid valve other diagnostic studies

CDC on Ebsteins anomaly of the tricuspid valve other diagnostic studies

Ebsteins anomaly of the tricuspid valve other diagnostic studies in the news

Blogs on Ebsteins anomaly of the tricuspid valve other diagnostic studies

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]}; Keri Shafer, M.D. [4] Priyamvada Singh, MBBS [[5]] Assistant Editor-In-Chief: Kristin Feeney, B.S. [[6]]

Overview

Electrophysiological Test

ACC / AHA 2008 Guidelines- Recommendation for Electrophysiology Testing/Pacing Issues - Ebstein’s Anomaly of the Tricuspid Valve(DO NOT EDIT)

Class IIa
"1.Catheter ablation can be beneficial for treatment of recurrent supraventricular tachycardia in some patients with Ebstein’s anomaly.(Level of Evidence: B) "
  • May be done in patients with rhythm disturbances like tachyarrhythmias, aberrant pathway (atrioventricular bypass). These studies help in identifying these pathways prior to ablation procedure.

References

Template:WH

Template:WS